We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$752M
AUM Growth
+$110M
Cap. Flow
+$81.1M
Cap. Flow %
10.79%
Top 10 Hldgs %
40.28%
Holding
184
New
49
Increased
34
Reduced
33
Closed
54

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.2M
2
ORCL icon
Oracle
ORCL
+$13.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$12.5M
4
NGD
New Gold Inc
NGD
+$10.2M
5
INCY icon
Incyte
INCY
+$9.49M

Sector Composition

Rank Sector Weight
1 Healthcare 17.31%
2 Technology 13.37%
3 Materials 7.6%
4 Utilities 6.6%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTNA
176
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
-220,000
Closed -$4.18M
HZNP
177
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-40,000
Closed -$475K
AKAO
178
DELISTED
Achaogen Inc
AKAO
-10,000
Closed -$217K
JUNO
179
DELISTED
Juno Therapeutics, Inc.
JUNO
-10,000
Closed -$299K
GIMO
180
PUT
DELISTED
Gigamon Inc.
GIMO
-300,000
Closed -$11.8M
ABCO
181
DELISTED
Advisory Board Co
ABCO
-95,000
Closed -$4.89M
ZGNX
182
DELISTED
Zogenix, Inc.
ZGNX
-15,000
Closed -$217K
ATVI
183
DELISTED
Activision Blizzard
ATVI
-7,000
Closed -$403K
CY
184
DELISTED
Cypress Semiconductor
CY
-275,000
Closed -$3.75M

Similar funds

Ardsley Advisory Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Ardsley Advisory Partners held 184 positions worth $752M, up 17% from $642M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Ardsley Advisory Partners deployed $81.1M of net new capital in Q3 2017, opening 49 new positions and adding to 34 existing holdings. Its largest new stake was Centene: 400,000 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Celgene Corp, an estimated $17.2M trimmed.

  • Ardsley Advisory Partners's largest Q3 2017 buy was Centene: 400,000 shares worth $19.4M.
  • Ardsley Advisory Partners added most to Zimmer Biomet in Q3 2017, an estimated $12.5M increase.
  • Ardsley Advisory Partners's biggest Q3 2017 reduction was Celgene Corp, cutting an estimated $17.2M.
  • Ardsley Advisory Partners fully exited Bluerock Residential Growth REIT, Inc. in Q3 2017, selling an estimated $8.05M.
  • Ardsley Advisory Partners's ten largest holdings make up 40% of its $752M portfolio in Q3 2017.
  • Ardsley Advisory Partners opened 49 new positions and closed 54 in Q3 2017.
  • Ardsley Advisory Partners's portfolio value rose 17% quarter-over-quarter to $752M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2017, filed 14 Nov 2017.